Ex Vivo Expansion of Haematopoietic Stem Cells to Improve Engraftment in Stem Cell Transplantation

Methods in Molecular Biology

Volumn 761, Issue , 2011, Pages 249-260

  Ko, Kap Hyoun ^a   Nordon, Robert ^a   O’Brien, Tracey A ^b   Symonds, Geoff ^c   Dolnikov, Alla ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

cell division; expansion; Haematopoietic stem cell

Indexed keywords

5 (6) CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; 5-(6)-CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; CD34 ANTIGEN; DIAGNOSTIC AGENT; FLUORESCEIN DERIVATIVE; SUCCINIMIDE DERIVATIVE;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; FETUS BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; METABOLISM; STAINING;

ANTIGENS, CD34; CELL DIFFERENTIATION; CELL PROLIFERATION; CORD BLOOD STEM CELL TRANSPLANTATION; FETAL BLOOD; FLOW CYTOMETRY; FLUORESCEINS; HEMATOPOIETIC STEM CELLS; HUMANS; STAINING AND LABELING; SUCCINIMIDES;

EID: 79960953598     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-61779-182-6_17     Document Type: Chapter

References (19)

1. Copelan, E. A. (2006). Hematopoietic stem-cell transplantation. N. Engl. J. Med. 354, 1813–1826.
2. Gluckman, E., Rocha, V., and Chastang, C. L. (1999). Umbilical cord blood hematopoietic stem cell transplantation. Cancer Treat. Res. 101, 79–96.
3. Scheding, S., Meister, B., Buhring, H. J., Baum, C., McKearn, J. P., Bock, T., et al. (2000). Effective ex vivo generation of granu-lopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells. Exp. Hematol. 28, 460–470.
4. Wingard, J. R., Vogelsang, G. B., and Deeg, H. J. (2002). Stem cell transplantation supportive care and long-term complications. Hematology (Am. Soc. Hematol. Educ. Pro-gram) 1, 422–444.
5. Haylock, D. N., and Nilsson, S. K. (2007). Expansion of umbilical cord blood for clinical transplantation. Curr. Stem Cell Res. Ther. 2, 324–335.
6. Brunstein, C. G., and Laughlin, M. J. (2010). Extending cord blood transplant to adults: dealing with problems and results overall. Semin. Hematol. 47, 86–96.
7. McNiece, I., Jones, R., Cagnoni, P., Bear-man, S., Nieto, Y., and Shpall, E. (1999). Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer. Hematol. Cell Ther. 41, 82–86.
8. Takagi, M. (2005). Cell processing engineering for ex-vivo expansion of hematopoietic cells. J. Biosci. Bioeng. 99, 189–196.
9. Madkaikar, M., Ghosh, K., Gupta, M., Swaminathan, S., and Mohanty, D. (2007). Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells. Acta Haematol. 118, 153–159.
10. Kelly, S. S., Sola, C. B., de Lima, M., and Shpall, E. (2009). Ex vivo expansion of cord blood. Bone Marrow Transplant. 44, 673–681.
11. Yao, C. L., Feng, Y. H., Lin, X. Z., Chu, I. M., Hsieh, T. B., and Hwang, S. M. (2006). Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133(+) cells. Stem Cells Dev. 15, 70–78.
12. Mobest, D., Mertelsmann, R., and Hen-schler, R. (1998). Serum-free ex vivo expansion of CD34(+) hematopoietic progenitor cells. Biotechnol. Bioeng. 60, 341–347.
13. Heike, T., and Nakahata, T. (2002). Ex vivo expansion of hematopoietic stem cells by cytokines. Biochim. Biophys. Acta 1592, 313–321.
14. Rose-John, S. (2006). Designer cytokines for human haematopoietic progenitor cell expansion: impact for tissue regeneration. Handb. Exp. Pharmacol. 174, 229–247.
15. McNiece, I. K., Almeida-Porada, G., Shpall, E. J., and Zanjani, E. (2002). Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. Exp. Hematol. 30, 612–616.
16. Peters, S. O., Kittler, E. L., Ramshaw, H. S., and Quesenberry, P. J. (1995). Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. Exp. Hematol. 23, 461–469.
17. Ko, K. H., Odell, R., and Nordon, R. E. (2007). Analysis of cell differentiation by division tracking cytometry. Cytometry A 71, 773–782.
18. Koeffler, H. P., Billing, R., Lusis, A. J., Sparkes, R., and Golde, D. W. (1980). An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood 56, 265–273.
19. Nordon, R. E., Nakamura, M., Ramirez, C., and Odell, R. (1999). Analysis of growth kinetics by division tracking. Immunol. Cell Biol. 77, 523–529.